Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gruber

Showing results (311-320 of 323) with videos related to

Pageof 33
Sort By:
Vaccine|January 24, 2026
Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccinesWilliam P Hausdorff, Marco Cavaleri, Marion F Gruber, et al.
Iscience|June 6, 2022
Toward understanding the communication in sperm whalesJacob Andreas, Gašper Beguš, Michael M Bronstein, et al.
Lancet (London, England)|September 17, 2021
Considerations in boosting COVID-19 vaccine immune responsesPhilip R Krause, Thomas R Fleming, Richard Peto, et al.
Plos One|December 11, 2025
An open-source bio-logger for studying cetacean behavior and communicationDaniel M Vogt, Joseph DelPreto, Michael Salino-Hugg, et al.
JAMA Pediatrics|May 22, 2023
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 YearsMao Hu, Hui Lee Wong, Yuhui Feng, et al.
Plos One|November 24, 2025
Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United StatesShelby S Fisher, Arnstein Lindaas, Stella G Muthuri, et al.
Pharmacoepidemiology and Drug Safety|May 6, 2025
Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 Months and Older in the United StatesPatricia C Lloyd, Elizabeth R Smith, Joann F Gruber, et al.
JAMA Network Open|April 24, 2024
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 YearsMao Hu, Azadeh Shoaibi, Yuhui Feng, et al.
Vaccine: X|February 6, 2024
Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United StatesJ Bradley Layton, Lauren Peetluk, Hui Lee Wong, et al.
BMC Pediatrics|April 26, 2024
Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort studyRachel P Ogilvie, J Bradley Layton, Patricia C Lloyd, et al.
Pageof 33

Showing results (311-320 of 323) with videos related to

Sort By:
Pageof 33
Vaccine|January 24, 2026
Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccinesWilliam P Hausdorff, Marco Cavaleri, Marion F Gruber, et al.
Iscience|June 6, 2022
Toward understanding the communication in sperm whalesJacob Andreas, Gašper Beguš, Michael M Bronstein, et al.
Lancet (London, England)|September 17, 2021
Considerations in boosting COVID-19 vaccine immune responsesPhilip R Krause, Thomas R Fleming, Richard Peto, et al.
Plos One|December 11, 2025
An open-source bio-logger for studying cetacean behavior and communicationDaniel M Vogt, Joseph DelPreto, Michael Salino-Hugg, et al.
JAMA Pediatrics|May 22, 2023
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 YearsMao Hu, Hui Lee Wong, Yuhui Feng, et al.
Plos One|November 24, 2025
Risk of neurologic or immune-mediated adverse events after COVID-19 diagnosis in the United StatesShelby S Fisher, Arnstein Lindaas, Stella G Muthuri, et al.
Pharmacoepidemiology and Drug Safety|May 6, 2025
Safety Monitoring of Bivalent COVID-19 mRNA Vaccines Among Recipients 6 Months and Older in the United StatesPatricia C Lloyd, Elizabeth R Smith, Joann F Gruber, et al.
JAMA Network Open|April 24, 2024
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 YearsMao Hu, Azadeh Shoaibi, Yuhui Feng, et al.
Vaccine: X|February 6, 2024
Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United StatesJ Bradley Layton, Lauren Peetluk, Hui Lee Wong, et al.
BMC Pediatrics|April 26, 2024
Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort studyRachel P Ogilvie, J Bradley Layton, Patricia C Lloyd, et al.
Pageof 33